U.S. Real Estate Stock News

Tempus AI (TEM) has been making headlines thanks to a series of high-profile collaborations, most notably a $200 million cancer research partnership with AstraZeneca. The company is also expanding its reach with new multi-year deals alongside leading academic and pharmaceutical players. These partnerships highlight Tempus AI’s growing profile as a central figure in AI-driven healthcare. For investors watching the stock, the focus is shifting from whether the company is building momentum to...

Whilst it may not be a huge deal, we thought it was good to see that the Epsilon Energy Ltd. ( NASDAQ:EPSN ) President...

Key Insights Donaldson Company's estimated fair value is US$93.51 based on 2 Stage Free Cash Flow to Equity Donaldson...

In recent days, Enanta Pharmaceuticals initiated a lawsuit against Pfizer in the European Unified Patent Court, alleging infringement of a newly granted COVID-19 antiviral patent, while Pfizer and Astellas announced positive Phase 3 results for PADCEV plus KEYTRUDA in muscle-invasive bladder cancer patients not eligible for cisplatin-based therapy. This combination of promising cancer trial results and fresh EU patent litigation marks a pivotal period as Pfizer's innovation meets potential...

Earlier this month, QuidelOrtho entered a new credit agreement providing over US$3 billion in senior secured term loans and revolving credit facilities, replacing its prior credit agreement and introducing new financial covenants tied to leverage and interest coverage ratios. This substantial debt financing comes as the company faces declining constant currency revenue and reduced free cash flow margin, raising ongoing questions about its profitability outlook and capacity for future...

Labcorp Holdings just made headlines with the rollout of the FDA-cleared Lumipulse pTau-217/Beta Amyloid 42 Ratio test, the first blood-based diagnostic of its kind to aid Alzheimer’s disease diagnosis. This isn’t just another product launch. For investors, the move addresses a real need in the market by offering a more affordable, accessible, and less invasive alternative to lumbar punctures and PET scans. With updated clinical guidelines now supporting blood-based biomarkers, Labcorp’s...

Microsoft (MSFT) just announced a major extension of its partnership with the NFL, rolling out next-generation AI tools like Copilot and Azure AI across the league’s teams, operations, and even fan experiences. This deal is more than just a headline grabber; it puts Microsoft’s AI innovations at the center of one of the world’s biggest sports stages, reaching coaches, players, analysts, and millions of fans. For investors evaluating where Microsoft’s AI ambitions are making an impact in the...

NetApp (NTAP) has been turning heads lately, landing on widely followed stock watchlists after new analyst coverage signaled a stable earnings outlook and moderate growth potential in key areas like services and cloud revenue. The company’s appearance among the most searched stocks comes as guidance remains positive for both the current and next fiscal years. Wall Street is watching closely for signs that NetApp can deliver steady results despite modest declines in some earnings forecasts...

Lowe's Companies reported its second quarter 2025 earnings, with sales of US$23.96 billion and net income of US$2.40 billion, alongside updated full-year guidance reflecting the addition of ADG and slightly adjusted operating margin and earnings expectations. A key insight is that while Lowe's included ADG in its outlook and revised margin guidance, expectations for its core business performance in fiscal 2025 remain unchanged, signaling a focus on integration rather than shifts in...

If you hold or follow NetScout Systems (NTCT), this week’s fiscal first quarter report probably made you pause and take notice. The company delivered both revenue and EPS numbers above what the market was expecting, which is a welcome sign for shareholders after some lackluster results in previous quarters. The main drivers were higher product revenue and a notable expansion in the product backlog. Together, these led management to raise their full-year revenue outlook. That guidance boost,...

Hilton Worldwide Holdings recently reported second-quarter 2025 results, surpassing analyst expectations for both earnings and revenues, while adding 221 hotels to its portfolio despite ongoing headwinds from reduced government spending and softer international travel. This performance highlights Hilton’s ability to maintain growth momentum through its continued expansion across luxury and lifestyle brands in the face of industry challenges. Let's explore how Hilton's strong quarterly...

Advanced Drainage Systems (NYSE:WMS) surprised many investors with its latest quarterly earnings, turning in results that topped Wall Street’s forecasts for both revenue and operating income. Even with hurdles like persistent wet weather slowing some projects and higher interest rates squeezing budgets, management showed it could adapt and keep profits on track. For investors who have been following the stock’s ups and downs, this kind of resilience stands out, especially when others in the...

If you are weighing your next move with H World Group (NasdaqGS:HTHT), this week’s events should not go unnoticed. The company’s stock jumped 5% after releasing second-quarter results that showed not only solid revenue and net income growth, but also operational momentum in its manachised and franchised hotel segments. Management’s optimism was backed up with a dividend hike and guidance for further top-line improvements in the third quarter. This suggests the business is keen to reward...

Karooooo (NASDAQ:KARO) has had a great run on the share market with its stock up by a significant 8.1% over the last...

AeroVironment (AVAV) just hit a major milestone that has investors taking notice. The company successfully delivered its advanced P550 small Unmanned Aircraft Systems to the U.S. Army under the Long-Range Reconnaissance program. This initial shipment is a significant development for AeroVironment’s latest product line and signals real-world progress instead of just pipeline hype. The P550’s modular architecture, quick field integration, and future-proof design are notable features that...

Helios Technologies recently experienced a golden cross, with its 50-day moving average crossing above its 200-day moving average, often interpreted as a technical indicator of potential bullish momentum. This technical development, coupled with recent positive revisions to earnings estimates, has highlighted increased optimism in the company’s future prospects among analysts. We'll examine how the combination of a bullish technical signal and upgraded earnings outlook impacts Helios...

EVERTEC, Inc. recently announced it has entered into a definitive agreement to acquire a 75% controlling stake in Tecnobank, a leading fintech company in Brazil’s digital vehicle financing contract registration sector, for approximately US$144 million, with the transaction expected to close in the fourth quarter of 2025 pending regulatory approval. This deal marks a substantial move for EVERTEC, signaling its deeper commitment to the Brazilian fintech space and further geographical...

If you’ve been tracking Sterling Infrastructure (STRL), you probably noticed the recent headlines around its E-Infrastructure Solutions segment. It’s not often you see a business offsetting weaker housing numbers with a surge in demand for data centers and manufacturing facilities. That combination is fueling Sterling’s momentum right now. In addition, the company’s plan to acquire CEC Facilities Group introduces an interesting mix of organic and strategic growth drivers that could reshape...

In recent days, Virtu Financial received a Zacks Rank #1 (Strong Buy) and top Value rating, with multiple analysts revising earnings estimates upward and highlighting its undervaluation compared to industry peers. This wave of analyst upgrades and positive sentiment signals increasing market confidence in Virtu’s earnings outlook and long-term positioning. Strong earnings outlook, as reflected in the latest analyst actions, is underscoring Virtu Financial's reputation as an attractive value...

Compass (NYSE:COMP) is catching the attention of investors after shares surged more than 8% as Federal Reserve Chair Jerome Powell indicated interest rate cuts could be coming soon. It is an important signal for the real estate sector, as lower rates tend to drive down mortgage costs, often reviving housing demand and providing a lift to real estate-focused businesses. On top of that, Compass reported its best-ever second quarter, expanding market share even while much of the industry...

Earlier this month, JLL announced the launch of artificial intelligence capabilities as an add-on to Prism, its building operations platform, introducing predictive operational intelligence, advanced data analysis, and conversational AI for property management teams. This advancement equips property professionals to streamline workflows, automate administrative tasks, and make more data-driven decisions, potentially redefining technology standards in commercial real estate management. We’ll...

If you’re eyeing Zebra Technologies (ZBRA) this week, the company just rolled out a fresh collaboration with the NFL’s Indianapolis Colts that could catch your attention. Zebra’s RFID-based MotionWorks Sport system will track player and ball data in Colts practice sessions, giving both coaches and players real-time insights into speed, distance, and formation metrics. With this deal, Zebra is doubling down on its presence across the NFL. The adoption of its tracking platform appears to be...

Black Stone Minerals (NYSE:BSM) has given investors a lot to digest lately. The CEO, Thomas L. Carter, just picked up 41,000 shares, a move that shows real conviction from inside the company. At the same time, Black Stone announced a major farmout agreement with Ellipsis U.S. Onshore Holdings. This agreement covers a massive 270,000 gross acres in East Texas and is backed by a multi-year drilling commitment. However, the company also trimmed its quarterly dividend after signaling lower...

If you’ve been following Revolution Medicines (RVMD), you know this week brought a flurry of developments that could matter for anyone weighing their next move. Piper Sandler just initiated coverage with a confident nod, while the company itself is touting progress in key Phase 3 trials for daraxonrasib and highlighting two recent FDA Breakthrough Therapy Designations. These milestones are watched closely by biotech investors and signal increased attention from both Wall Street and...